文献速递外周动脉疾病

慢性肢体威胁性缺血血运重建真实世界研究结局测量:范围综述与评价框架

Outcome Measurement in Real World Studies of Revascularisation for Chronic Limb Threatening Ischaemia: A Scoping Review and Framework for Appraisal.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2026-07-08

报告以死亡率、大截肢和再干预为主(合计46.8%),复合结局占19.5%;结局定义异质性大,再干预有22种定义。数据基础设施的编码颗粒度和链接能力影响结局有效性,作者据此提出评价框架。

要点

  • 真实世界CLTI血运重建研究结局以死亡、大截肢和再干预为主,患者报告结局、通畅率和伤口愈合报告较少。
  • 结局定义异质性显著,再干预存在22种定义,需标准化以提高证据可比性。
  • 数据链接(如与民事死亡登记链接)和肢体特异性手术编码可提升结局测量的可靠性。

核心结论

  • 真实世界CLTI血运重建研究的结局有效性受数据基础设施特征影响,尤其是编码颗粒度和链接能力。
  • 需标准化结局定义并整合数据基础设施,以支持更可靠、可解释的真实世界证据。

研究设计与样本

  • 范围综述,系统检索MEDLINE和Embase(2015—2025年)的观察性研究。

主要发现

  • 复合结局(无截肢生存、主要肢体不良事件、主要心血管不良事件)占19.5%。
  • 再干预有22种定义,结局定义异质性大。
  • 与民事死亡登记链接改善死亡率 ascertainment;肢体特异性手术分析支持的数据基础设施对截肢和再干预事件捕获最稳健。
  • 患者报告结局、通畅率和伤口愈合报告不频繁。

关键数值与推荐

  • 再干预共识别22种定义。
  • 死亡率、大截肢和再干预合计占所有报告结局的46.8%。
  • 复合结局占所有报告结局的19.5%。

临床怎么用

  • 解读真实世界CLTI血运重建研究时,应评估数据源的编码颗粒度和链接能力对结局有效性的影响。
  • 优先采用标准化结局定义,并利用登记-行政-死亡登记链接提升长期结局可靠性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Real world data are increasingly used to evaluate revascularisation outcomes in chronic limb threatening ischaemia (CLTI). However, variation in data availability, accuracy, completeness, and granularity may influence the validity of outcome measurement. This review mapped outcomes reported in real world studies of CLTI revascularisation, examined how data infrastructure limitations affected outcome measurement, and developed a framework for appraising the validity of reported outcomes. METHODS: This was a scoping review of observational studies evaluating CLTI revascularisation using standalone or linked national registry, administrative, and insurance based datasets. MEDLINE and Embase were searched systematically (2015 - 2025) for eligible studies. Extracted information included data source(s), country, outcome definitions, reporting frequency, time period(s) covered, and linkage status. Outcome measurement issues were assessed in relation to data infrastructure characteristics. RESULTS: Fifty five studies from 10 countries reported 293 outcomes (31 unique). Reporting was dominated by mortality, major amputation, and re-intervention, collectively accounting for 46.8% of all reported outcomes. Composite outcomes including amputation free survival, major adverse limb events, and major adverse cardiovascular events contributed a further 19.5%. Outcome definitions were heterogeneous, with 22 definitions of re-intervention identified. Linkage with civic death registers improved mortality ascertainment. Amputation and re-intervention event capture was most robust in data infrastructures supporting granular limb specific procedural analysis. Patient reported outcome measures, patency, and wound healing were reported infrequently. Linkage between registries, administrative datasets and death registers strengthened reliability of long term outcome measurement. A framework for appraising real world CLTI revascularisation studies reflects these observations. CONCLUSION: Outcome validity in real world studies of CLTI revascularisation is influenced by the characteristics of the underlying data infrastructures, particularly coding granularity and linkage capability. Greater standardisation of outcome definitions and improved integration of data infrastructures are required to support more reliable and interpretable real world evidence in CLTI.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Sheehan F, Birmpili P, Bicknell C, et al. Outcome Measurement in Real World Studies of Revascularisation for Chronic Limb Threatening Ischaemia: A Scoping Review and Framework for Appraisal. Eur J Vasc Endovasc Surg. 2026. PMID: 42413569. doi:10.1016/j.ejvs.2026.07.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。